| ARDS | Acute respiratory distress syndrome |
| BAL | Bronchoalveolar lavage |
| BL | Bronchiolitis |
| CD20 | Cluster of differentiation 20 |
| CDK 4/6 | Cyclin-dependent kinase 4 and 6 |
| CT | Computed tomography |
| CTCAE | Common Terminology Criteria for Adverse Events |
| DAD | Diffuse alveolar damage |
| DAH | Diffuse alveolar hemorrhage |
| FDA | Food and Drug Administration |
| HP | Hypersensitivity pneumonitis |
| ICI | Immune checkpoint inhibitor |
| HRCT | High-resolution computed tomography |
| NSIP | Nonspecific interstitial pneumonia |
| OP | Organizing pneumonia |
| PaO2 | Arterial partial pressure of oxygen |
| RRP | Radiation recall pneumonitis |
| SARS-CoV2 | Severe acute respiratory syndrome coronavirus 2 |
| SLR | Sarcoid-like reactions |
| SpO2 | Peripheral oxygen saturation of hemoglobin |